Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 1
2009 1
2010 6
2012 3
2013 2
2014 1
2015 2
2016 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Maintenance treatment with antipsychotic drugs for schizophrenia.
Ceraso A, Lin JJ, Schneider-Thoma J, Siafis S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM, Leucht S. Ceraso A, et al. Cochrane Database Syst Rev. 2020 Aug 11;8(8):CD008016. doi: 10.1002/14651858.CD008016.pub3. Cochrane Database Syst Rev. 2020. PMID: 32840872 Free PMC article.
OBJECTIVES: To review the effects of maintaining antipsychotic drugs for people with schizophrenia compared to withdrawing these agents. SEARCH METHODS: We searched the Cochrane Schizophrenia Group's Study-Based Register of Trials including the registries of clinical trial …
OBJECTIVES: To review the effects of maintaining antipsychotic drugs for people with schizophrenia compared to withdrawing these agents. SEA …
Maintenance treatment with antipsychotic drugs for schizophrenia.
Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM. Leucht S, et al. Cochrane Database Syst Rev. 2012 May 16;(5):CD008016. doi: 10.1002/14651858.CD008016.pub2. Cochrane Database Syst Rev. 2012. PMID: 22592725 Updated. Review.
Hospitalisation was also reduced, however, the baseline risk was lower (drug 10%, placebo 26%, 16 RCT(s), n=2090, RR 0.38 CI 0.27 to 0.55, NNT 5 CI 4 to 9). More participants in the placebo group than in the antipsychotic drug group left the studies early due to any reason …
Hospitalisation was also reduced, however, the baseline risk was lower (drug 10%, placebo 26%, 16 RCT(s), n=2090, RR 0.38 CI 0.27 to …
Second-generation antipsychotics for obsessive compulsive disorder.
Komossa K, Depping AM, Meyer M, Kissling W, Leucht S. Komossa K, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008141. doi: 10.1002/14651858.CD008141.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154394 Review.
SEARCH STRATEGY: The Cochrane Depression, Anxiety and Neurosis Group's controlled trial registers (CCDANCTR-Studies and CCDANCTR-References) were searched up to 21 July 2010. ...
SEARCH STRATEGY: The Cochrane Depression, Anxiety and Neurosis Group's controlled trial registers (CCDANCTR-Studies and CCDANCTR-Refe …
Second-generation antipsychotics for anxiety disorders.
Depping AM, Komossa K, Kissling W, Leucht S. Depping AM, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008120. doi: 10.1002/14651858.CD008120.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154392 Review.
SEARCH STRATEGY: The Cochrane Depression, Anxiety and Neurosis Group's controlled trial registers (CCDANCTR-Studies and CCDANCTR-References) were searched up to 21 July 2010. ...Monotherapy with quetiapine seems to be efficacious in reducing symptoms of generalised anxiety …
SEARCH STRATEGY: The Cochrane Depression, Anxiety and Neurosis Group's controlled trial registers (CCDANCTR-Studies and CCDANCTR-Refe …
Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S. Komossa K, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008121. doi: 10.1002/14651858.CD008121.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154393 Review.
SEARCH STRATEGY: The Cochrane Depression, Anxiety and Neurosis Group's controlled trial registers (CCDANCTR-Studies and CCDANCTR-References) were searched up to 21 July 2010. ...
SEARCH STRATEGY: The Cochrane Depression, Anxiety and Neurosis Group's controlled trial registers (CCDANCTR-Studies and CCDANCTR-Refe …
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P, Suo T, Komossa K, Ma H, Rummel-Kluge C, El-Sayeh HG, Leucht S, Xia J. Khanna P, et al. Cochrane Database Syst Rev. 2014 Jan 2;2014(1):CD006569. doi: 10.1002/14651858.CD006569.pub5. Cochrane Database Syst Rev. 2014. PMID: 24385408 Free PMC article. Review.
Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S. Asmal L, et al. Cochrane Database Syst Rev. 2013 Nov 18;(11):CD006625. doi: 10.1002/14651858.CD006625.pub3. Cochrane Database Syst Rev. 2013. PMID: 24249315 Review.
18 results